ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
Dow Jones
38,686.32
1.51%
Brent Oil
81.295
0.00%
Bitcoin
67,718.30
-0.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Longboard Pharmaceuticals Inc (LBPH)

  7. Longboard Pharmaceuticals Inc (LBPH) News

LBPH

Longboard Pharmaceuticals (LBPH)

Longboard Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LBPH
DateTimeSourceHeadlineSymbolCompany
05/24/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/24/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/06/20244:01PMBusiness WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
05/02/20244:01PMBusiness WireLongboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/03/20249:00AMBusiness WireLongboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15NASDAQ:LBPHLongboard Pharmaceuticals Inc
04/02/20244:00PMBusiness WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/12/20244:01PMBusiness WireLongboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/20244:01PMBusiness WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/02/20244:30PMBusiness WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/20248:30AMBusiness WireLongboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in FebruaryNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/08/20244:05PMBusiness WireLongboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/04/20244:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/04/20244:48PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/03/20249:40PMBusiness WireLongboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/03/20248:59PMEdgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/20244:54PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/20244:01PMBusiness WireLongboard Pharmaceuticals Announces Commencement of Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/20249:44AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/20248:00AMBusiness WireLongboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/01/20244:47PMBusiness WireLongboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
11/29/20238:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
11/29/20238:30AMBusiness WireLongboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy VolunteersNASDAQ:LBPHLongboard Pharmaceuticals Inc
11/21/20234:00PMBusiness WireLongboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy CommunityNASDAQ:LBPHLongboard Pharmaceuticals Inc
11/03/20234:01PMBusiness WireLongboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
11/02/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
11/02/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
11/02/20234:01PMBusiness WireLongboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
11/01/20238:30AMBusiness WireLongboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in NovemberNASDAQ:LBPHLongboard Pharmaceuticals Inc
10/11/20239:26AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:LBPH

Your Recent History

BIT
P1AJ68
BNP Paribas Issuance
BOV
PNVL3
DIMED ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved